Cephalalgia

Prophylactic treatment of migraine in children. Part 2. A systematic review of pharmacological trials
pp. 497-505(9)
Authors: Damen, L; Bruijn, J; Verhagen, AP; Berger, MY; Passchier, J; Koes, BW

Prevalence of unexplained upper abdominal symptoms in patients with migraine
pp. 506-510(5)
Authors: Kurth, T; Holtmann, G; Neufang-Hüber, J; Gerken, G; Diener, H-C

Brainstem dysfunction in alternating hemiplegia of childhood: a neurophysiological study
pp. 511-519(9)
Authors: Rinalduzzi, S; Valeriani, M; Vigevano, F

Acupuncture in migraine prophylaxis: a randomized sham-controlled trial
pp. 520-529(10)
Authors: Alecrim-Andrade, J; Maciel-Júnior, JA; Cladellas, XC; Correa-Filho, HR; Machado, HC

Is vasospasm requisite for posterior leukoencephalopathy in patients with primary thunderclap headaches?
pp. 530-536(7)
Authors: Chen, S-P; Fuh, J-L; Lirng, J-F; Wang, S-J

Efficacy and tolerability of diclofenac potassium sachets in migraine: a randomized, double-blind, cross-over study in comparison with diclofenac potassium tablets and placebo
pp. 537-547(11)
Authors: Diener, H-C; Montagna, P; Gács, G; Lyczak, P; Schumann, G; Zöller, B; Mulder, Ljmm; Siegel, J; Edson, K

The relationship between migraine pain and other associated symptoms
pp. 548-553(6)
Authors: Kelman, L; Tanis, D

Visual cortical inhibitory function in migraine is not generally impaired: evidence from a combined psychophysical test with an fMRI study
pp. 554-560(7)
Authors: Huang, J; DeLano, M; Cao, Y

Deep brain stimulation for neuropathic cephalalgia
pp. 561-567(7)
Authors: Green, AL; Owen, SLF; Davies, P; Moir, L; Aziz, TZ

Patterns of experimentally induced pain in pericranial muscles
pp. 568-577(10)
Authors: Schmidt-Hansen, PT; Svensson, P; Jensen, TS; Graven-Nielsen, T; Bach, FW

Clinical features and pharmacological treatment of migraine patients referred to headache specialists in Canada
pp. 578-588(11)
Authors: Jelinski, SE; Becker, WJ; Christie, SN; Giammarco, R; Mackie, GF; Gawel, MJ; Eloff, AG; Magnusson, JE

Outcome of medication overuse headache after abrupt in-patient withdrawal
pp. 589-595(7)
Authors: Relja, G; Granato, A; Bratina, A; Antonello, RM; Zorzon, M

Cognitive and behavioural effects of migraine in childhood and adolescence
pp. 596-603(8)
Authors: Riva, D; Aggio, F; Vago, C; Nichelli, F; Andreucci, E; Paruta, N; D'Arrigo, S; Pantaleoni, C; Bulgheroni, S

Outcome of headache frequency in adolescence
pp. 604-612(9)
Authors: Laimi, K; Metsähonkala, L; Anttila, P; Aromaa, M; Vahlberg, T; Salminen, JJ; Sillanpää, M

Orthostatic hypacusis in a patient with CSF hypovolaemia
pp. 613-616(4)
Authors: Chung, SJ; Ahn, JH; Lee, J-H; Im, J-H; Lee, MC

Cluster headache attack due to sildenafil intake
pp. 617-619(3)
Authors: de L Figuerola, M; Bruera, O; Lestón, J; Ferreiro, J

Secondary SUNCT syndrome to a variant of the vertebrobasilar vascular development
pp. 620-622(3)
Authors: Mondéjar, B; Cano, EF; Pérez, I; Navarro, S; Garrido, JA; Velásquez, JM; Alvarez, A

Predictors of hazardous alcohol consumption among patients with cluster headache
pp. 623-627(5)
Authors: Schürks, M; Kurth, T; Knorn, P; Pageler, L; Diener, H-C

Oral triptans vs. other classes of acute migraine medication
pp. 628-628(1)

Migraine and silent infarcts. Are we making the proper decisions?
pp. 629-630(2)

ANNOUNCEMENT
pp. 631-631(1)